Nicholas Investment Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-12,574
Closed -$2.9M 355
2016
Q3
$2.9M Buy
12,574
+1,462
+13% +$357K 0.19% 210
2016
Q2
$2.57M Buy
11,112
+4,331
+64% +$999K 0.18% 229
2016
Q1
$1.82M Sell
6,781
-5,174
-43% -$1.48M 0.13% 250
2015
Q4
$3.74M Buy
11,955
+4,836
+68% +$1.44M 0.26% 167
2015
Q3
$1.94M Sell
7,119
-7,263
-51% -$2.23M 0.14% 248
2015
Q2
$4.36M Buy
14,382
+3,254
+29% +$971K 0.28% 127
2015
Q1
$3.31M Buy
11,128
+2,470
+29% +$704K 0.21% 207
2014
Q4
$2.23M Hold
8,658
0.14% 236
2014
Q3
$2.09M Sell
8,658
-41,044
-83% -$9.19M 0.13% 234
2014
Q2
$11.1M Buy
49,702
+25,840
+108% +$5.35M 0.65% 23
2014
Q1
$4.91M Buy
23,862
+156
+0.7% +$30.9K 0.41% 56
2013
Q4
$3.98M Buy
23,706
+6,324
+36% +$989K 0.3% 75
2013
Q3
$2.5M Sell
17,382
-2,565
-13% -$342K 0.21% 158
2013
Q2
$2.52M Buy
+19,947
New +$2.26M 0.23% 124

Other funds holding AGN

Nicholas Investment Partners's AGN Position: Q4 2016 in Review

Nicholas Investment Partners sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 12,574 shares — an estimated $2.9M sold.

Nicholas Investment Partners first reported a position in AGN in Q2 2013 and held it in 14 quarters. The position peaked at $11.1M in Q2 2014. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Nicholas Investment Partners reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Nicholas Investment Partners sold 12,574 Allergan plc shares in Q4 2016, an estimated $2.9M.
  • Nicholas Investment Partners first reported a position in Allergan plc in Q2 2013 and held it in 14 quarters.
  • Nicholas Investment Partners's Allergan plc position peaked at $11.1M in Q2 2014.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Nicholas Investment Partners's 13F filing for Q4 2016, filed 10 Feb 2017.